Approval · Notice of Compliance 27950 · 2022
SEMGLEE: Notice of Compliance 27950
Issued April 8, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27950
- Date
- April 8, 2022
- Company
- BGP Pharma ULCEtobicoke, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- LANTUS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SEMGLEE | 02526441 | Marketed |
Medicinal ingredients
- INSULIN GLARGINE 100 UNIT per ML